Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials.

Authors

Daniel Brie
Amirhossein Sahebkar
Peter E Penson
Madalina Dinca
Sorin Ursoniu
Maria-Corina Serban
Alberto Zanchetti
George Howard
Ali Ahmed, George Washington University
Wilbert S Aronow
Paul Muntner
Gregory Y H Lip
Nathan D Wong
Jacek Rysz
Maciej Banach

Document Type

Journal Article

Publication Date

12-1-2016

Journal

Journal of hypertension

Volume

34

Issue

12

Inclusive Pages

2318-2329

DOI

10.1097/HJH.0000000000001086

Keywords

Biomarkers; Blood Pressure; C-Reactive Protein; Humans; Interleukin-6; Pentoxifylline; Phosphodiesterase Inhibitors; Randomized Controlled Trials as Topic; Tumor Necrosis Factor-alpha

APA Citation

Brie, D., Sahebkar, A., Penson, P., Dinca, M., Ursoniu, S., Serban, M., Zanchetti, A., Howard, G., Ahmed, A., Aronow, W., Muntner, P., Lip, G., Wong, N., Rysz, J., & Banach, M. (2016). Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials.. Journal of hypertension, 34 (12). http://dx.doi.org/10.1097/HJH.0000000000001086

Peer Reviewed

1